Epizyme
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Epizyme's past years’ income statements indicate that its last revenue has increased compared to the previous period by 137% to $37,427,000. Profit margin reached -671%. Total operating expenses were $264,921,000.

Profit Margin

Epizyme, Inc. (NASDAQ:EPZM): Profit margin
2012 45.22M -702K -1.55%
2013 68.48M -3.48M -5.09%
2014 41.41M -55.00M -132.83%
2015 2.56M -132.37M -5170.94%
2016 8.00M -110.21M -1376.45%
2017 10M -134.30M -1343.09%
2018 21.7M -123.63M -569.72%
2019 23.8M -170.29M -715.53%
2020 15.76M -231.69M -1469.95%
2021 37.42M -251.12M -670.96%

EPZM Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
37.42M15.76M23.8M21.7M10M8.00M2.56M41.41M68.48M45.22M
Cost of revenue
10.49M5.06M00000000
Gross profit
26.92M10.69M23.8M21.7M10M8.00M2.56M41.41M68.48M0
Operating exp.
Research and development
130.96M110.93M132.63M105.83M109.66M91.46M111.20M75.59M57.56M38.48M
Selling and marketing
0000000000
Total operating expenses
264.92M236.11M200.94M149.80M146.84M119.83M135.10M96.46M71.60M45.99M
Operating income
-226.93M-225.41M-177.14M-128.10M-136.84M-111.82M-132.54M-55.05M-3.12M-768K
Other income (expenses), net
-24.16M-6.16M6.90M4.53M2.19M1.61M173K154K-7K67K
Income before tax
-251.1M-231.58M-170.23M-123.57M-134.64M-110.21M-132.37M-54.89M-3.13M-701K
Income tax expense
22K114K58K57K-336K1.61M173K109K349K1K
Net income
-251.12M-231.69M-170.29M-123.63M-134.30M-110.21M-132.37M-55.00M-3.48M-702K
Earnings per share
Basic EPS
-2.49-2.29-1.89-1.72-2.18-1.93-3.32-1.67-0.2-0.03
Diluted EPS
-2.49-2.29-1.89-1.72-2.18-1.93-3.32-1.67-0.2-0.03
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source